EUVIMEDEUVIMED entdecken
Crossref

IMP3 Immunohistochemical Expression Is Related with Progression and Metastases in Xenografted and Cutaneous Melanomas

Natividad Martin-Morales, Miguel Padial-Molina, Isabel Tovar, Virginea De Araujo Farias, Pedro Hernández-Cortés, Esperanza Ramirez-Moreno, Mercedes Caba-Molina, Justin Davis, Alejandro Carrero Castaño, Jose Mariano Ruiz de Almodovar, Pablo Galindo-Moreno, Javier Oliver-Pozo und 1 weitere

Pathobiology · 2024

DOI: 10.1159/000533916 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pathobiology, 2024. Verfasst von Natividad Martin-Morales und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, University of Granada, Granada, Spain, nati@ugr.es. Hauptthemen laut MEDLINE: Melanoma, Skin Neoplasms. Die Arbeit nennt 41 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Insulin-like growth factor-II messenger RNA-binding protein-3 (IMP3) over-expression is a predictor of tumor recurrence and metastases in some types of human melanoma. Our objective was to evaluate the immunohistochemical expression of IMP3 and other molecules related to tumor prognosis in melanoma-xeno-tumors undergoing treatment. We test the effect of radiotherapy (RT) and mesenchymal stromal cells (MSCs) treatment, analyzing the tumorigenic and metastatsizing capacity in a mice melanoma xenograft model. Materials and Methods: We inoculated A375 and G361 human melanoma cell lines into NOD/SCID gamma mice (n = 64). We established a control group, a group treated with MSCs, a group treated with MSCs plus RT, and a group treated with RT. We assessed the immunohistochemical expression of IMP3, E-cadherin, N-cadherin, PARP1, HIF-1α, and the proliferation marker Ki-67. Additionally, we performed a retrospective study including 114 histological samples of patients diagnosed with malignant cutaneous superficial spreading melanoma (n = 104) and nodular melanoma (n = 10) with at least 5 years of follow-up.

Results

Most morphological and immunohistochemical features show statistically significant differences between the 2 cell lines. The A375 cell line induced the formation of metastases, while the G361 cell line provoked tumor formation but not metastases. All three treatments reduced the cell proliferation evaluated by the Ki-67 nuclear antigen (p = 0.000, one-way ANOVA test) and reduced the number of metastases (p = 0.004, one-way ANOVA test). In addition, the tumor volumes reduced in comparison with the control groups, 31.74% for RT + MSCs in the A357 tumor cell line, and 89.84% RT + MSCs in the G361 tumor cell line. We also found that IMP3 expression is associated with greater tumor aggressiveness and was significantly correlated with cell proliferation (measured by the expression of Ki-67), the number of metastases, and reduced expression of adhesion molecules.

Conclusions

The combined treatment of RT and MSCs on xenografted melanomas reduces tumor size, metastases frequency, and the epithelial to mesenchymal transition/PARP1 metastatic phenotype. This treatment also reduces the expression of molecules related to cellular proliferation (Ki-67), molecules that facilitate the metastatic process (E-cadherin), and molecules related with prognosis (IMP3).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MelanomaSkin NeoplasmsAnimalsMiceHumansKi-67 AntigenRetrospective StudiesHeterograftsEpithelial-Mesenchymal TransitionMice, Inbred NODMice, SCIDCell Line, TumorCadherinsBiomarkers, Tumor

Stichwörter der Autor:innen

ImmunohistochemicalInsulin-like growth factor-II messenger RNA-binding protein-3MelanomaMesenchymal stromal cellsRadiotherapy

Substanzen

Ki-67 AntigenCadherinsBiomarkers, Tumor

Autor:innen und Institutionen

  • Department of Pathology, University of Granada, Granada, Spain, nati@ugr.es.
  • Department of Oral Surgery and Implant Dentistry, School of Dentistry, University of Granada, Granada, Spain, nati@ugr.es.
  • Department of Oral Surgery and Implant Dentistry, School of Dentistry, University of Granada, Granada, Spain.
  • Biosanitary Institute (Ibs.GRANADA), Granada, Spain.
  • Department of Oncology and Radiotherapy, Virgen de las Nieves University Hospital, Granada, Spain.
  • Institute of Biopathology and Medicine Regenerative (IBIMER, CIBM), University of Granada, Granada, Spain.

Zitieren

APA

Martin-Morales, N., Padial-Molina, M., Tovar, I., De Araujo Farias, V., Hernández-Cortés, P., Ramirez-Moreno, E., Caba-Molina, M., Davis, J., Carrero Castaño, A., Ruiz de Almodovar, J. M., Galindo-Moreno, P., Oliver-Pozo, J., & O'Valle Ravassa, F. J. (2024). IMP3 Immunohistochemical Expression Is Related with Progression and Metastases in Xenografted and Cutaneous Melanomas. Pathobiology. https://doi.org/10.1159/000533916

Vancouver

Martin-Morales N, Padial-Molina M, Tovar I, De Araujo Farias V, Hernández-Cortés P, Ramirez-Moreno E, et al. IMP3 Immunohistochemical Expression Is Related with Progression and Metastases in Xenografted and Cutaneous Melanomas. Pathobiology. 2024. doi:10.1159/000533916

BibTeX
@article{MartinMorales2024,
  author = {Martin-Morales, Natividad and Padial-Molina, Miguel and Tovar, Isabel and De Araujo Farias, Virginea and Hernández-Cortés, Pedro and Ramirez-Moreno, Esperanza and Caba-Molina, Mercedes and Davis, Justin and Carrero Castaño, Alejandro and Ruiz de Almodovar, Jose Mariano and Galindo-Moreno, Pablo and Oliver-Pozo, Javier and O'Valle Ravassa, Francisco Javier},
  title = {IMP3 Immunohistochemical Expression Is Related with Progression and Metastases in Xenografted and Cutaneous Melanomas},
  journal = {Pathobiology},
  year = {2024},
  doi = {10.1159/000533916}
}
Kostenlos starten →